Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ross Arena

Showing results (151-160 of 735) with videos related to

Pageof 74
Sort By:
Circulation|June 29, 2011
Pulmonary hypertension in heart failure with preserved ejection fraction: a target of phosphodiesterase-5 inhibition in a 1-year studyMarco Guazzi, Marco Vicenzi, Ross Arena, et al.
Chest|October 21, 2005
Influence of heart failure etiology on the prognostic value of peak oxygen consumption and minute ventilation/carbon dioxide production slopeRoss Arena, Jonathan Myers, Joshua Abella, et al.
Future Cardiology|August 11, 2017
Obesity, body composition and cardiorespiratory fitness in heart failure with preserved ejection fractionSalvatore Carbone, Dejana Popovic, Carl J Lavie, et al.
International Journal of Cardiology|August 1, 2008
Six months of Sildenafil therapy improves heart rate recovery in patients with heart failureMarco Guazzi, Ross Arena, Sherry Pinkstaff, et al.
Circulation. Heart Failure|November 2, 2010
PDE5 inhibition with sildenafil improves left ventricular diastolic function, cardiac geometry, and clinical status in patients with stable systolic heart failure: results of a 1-year, prospective, randomized, placebo-controlled studyMarco Guazzi, Marco Vicenzi, Ross Arena, et al.
European Journal of Preventive Cardiology|February 6, 2013
Cardiopulmonary exercise testing reflects similar pathophysiology and disease severity in heart failure patients with reduced and preserved ejection fractionMarco Guazzi, Valentina Labate, Lawrence P Cahalin, et al.
JACC. Heart Failure|October 11, 2014
Colchicine in stable chronic heart failureBenjamin Van Tassell, Justin Canada, Ross Arena, et al.
Physical Therapy|October 31, 2021
Precision Medicine and Physical Therapy: A Healthy Living Medicine Approach for the Next CenturyRichard Severin, Ahmad Sabbahi, Ross Arena, et al.
Chest|December 4, 2019
Reference Standards for Ventilatory Threshold Measured With Cardiopulmonary Exercise Testing: The Fitness Registry and the Importance of Exercise: A National DatabaseBaruch Vainshelboim, Ross Arena, Leonard A Kaminsky, et al.
Journal of Cardiopulmonary Rehabilitation and Prevention|January 3, 2022
Focus on Healthy Living in the LGBTIQA+ Community: PRIMARY AND SECONDARY PREVENTION OF CARDIOVASCULAR DISEASE FOR ALLMargot McCrillis, Ryan Nini, Richard Severin, et al.
Pageof 74

Showing results (151-160 of 735) with videos related to

Sort By:
Pageof 74
Circulation|June 29, 2011
Pulmonary hypertension in heart failure with preserved ejection fraction: a target of phosphodiesterase-5 inhibition in a 1-year studyMarco Guazzi, Marco Vicenzi, Ross Arena, et al.
Chest|October 21, 2005
Influence of heart failure etiology on the prognostic value of peak oxygen consumption and minute ventilation/carbon dioxide production slopeRoss Arena, Jonathan Myers, Joshua Abella, et al.
Future Cardiology|August 11, 2017
Obesity, body composition and cardiorespiratory fitness in heart failure with preserved ejection fractionSalvatore Carbone, Dejana Popovic, Carl J Lavie, et al.
International Journal of Cardiology|August 1, 2008
Six months of Sildenafil therapy improves heart rate recovery in patients with heart failureMarco Guazzi, Ross Arena, Sherry Pinkstaff, et al.
Circulation. Heart Failure|November 2, 2010
PDE5 inhibition with sildenafil improves left ventricular diastolic function, cardiac geometry, and clinical status in patients with stable systolic heart failure: results of a 1-year, prospective, randomized, placebo-controlled studyMarco Guazzi, Marco Vicenzi, Ross Arena, et al.
European Journal of Preventive Cardiology|February 6, 2013
Cardiopulmonary exercise testing reflects similar pathophysiology and disease severity in heart failure patients with reduced and preserved ejection fractionMarco Guazzi, Valentina Labate, Lawrence P Cahalin, et al.
JACC. Heart Failure|October 11, 2014
Colchicine in stable chronic heart failureBenjamin Van Tassell, Justin Canada, Ross Arena, et al.
Physical Therapy|October 31, 2021
Precision Medicine and Physical Therapy: A Healthy Living Medicine Approach for the Next CenturyRichard Severin, Ahmad Sabbahi, Ross Arena, et al.
Chest|December 4, 2019
Reference Standards for Ventilatory Threshold Measured With Cardiopulmonary Exercise Testing: The Fitness Registry and the Importance of Exercise: A National DatabaseBaruch Vainshelboim, Ross Arena, Leonard A Kaminsky, et al.
Journal of Cardiopulmonary Rehabilitation and Prevention|January 3, 2022
Focus on Healthy Living in the LGBTIQA+ Community: PRIMARY AND SECONDARY PREVENTION OF CARDIOVASCULAR DISEASE FOR ALLMargot McCrillis, Ryan Nini, Richard Severin, et al.
Pageof 74